| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 30 | 2020 | 1475 | 2.270 |
Why?
|
| Photochemotherapy | 22 | 2004 | 807 | 2.180 |
Why?
|
| Carotid Stenosis | 23 | 2020 | 854 | 2.020 |
Why?
|
| Endarterectomy, Carotid | 19 | 2023 | 546 | 1.820 |
Why?
|
| Blood Vessel Prosthesis Implantation | 22 | 2022 | 1390 | 1.590 |
Why?
|
| Tunica Intima | 14 | 2011 | 464 | 1.560 |
Why?
|
| Ischemia | 17 | 2018 | 1907 | 1.490 |
Why?
|
| Carotid Body Tumor | 4 | 2020 | 32 | 1.280 |
Why?
|
| Blood Vessel Prosthesis | 21 | 2022 | 933 | 1.200 |
Why?
|
| Aortic Aneurysm, Abdominal | 24 | 2022 | 1186 | 1.190 |
Why?
|
| Angioplasty, Balloon | 14 | 2011 | 653 | 1.100 |
Why?
|
| Carotid Artery, Internal | 6 | 2018 | 445 | 1.020 |
Why?
|
| Arterial Occlusive Diseases | 13 | 2010 | 793 | 1.020 |
Why?
|
| Lower Extremity | 6 | 2012 | 1158 | 0.990 |
Why?
|
| Endovascular Procedures | 11 | 2022 | 1979 | 0.970 |
Why?
|
| Intermittent Claudication | 7 | 2012 | 309 | 0.920 |
Why?
|
| Muscle, Smooth, Vascular | 10 | 2004 | 1504 | 0.790 |
Why?
|
| Stents | 20 | 2021 | 3280 | 0.790 |
Why?
|
| Femoral Artery | 14 | 2009 | 845 | 0.760 |
Why?
|
| Leg | 11 | 2012 | 1116 | 0.730 |
Why?
|
| Carotid Arteries | 11 | 2020 | 952 | 0.670 |
Why?
|
| Aorta, Abdominal | 18 | 2003 | 646 | 0.650 |
Why?
|
| Popliteal Artery | 4 | 2009 | 317 | 0.600 |
Why?
|
| Iliac Artery | 9 | 2011 | 364 | 0.590 |
Why?
|
| Peripheral Vascular Diseases | 5 | 2010 | 550 | 0.580 |
Why?
|
| Hyperplasia | 19 | 2011 | 1185 | 0.570 |
Why?
|
| Postoperative Complications | 36 | 2021 | 15295 | 0.550 |
Why?
|
| Prosthesis Failure | 3 | 2012 | 1206 | 0.540 |
Why?
|
| Photosensitizing Agents | 9 | 2002 | 602 | 0.540 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2015 | 329 | 0.530 |
Why?
|
| Peripheral Arterial Disease | 5 | 2020 | 1188 | 0.520 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 391 | 0.500 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2015 | 233 | 0.490 |
Why?
|
| Extracellular Matrix | 6 | 2004 | 1741 | 0.490 |
Why?
|
| Catheterization | 5 | 2011 | 1470 | 0.440 |
Why?
|
| Graft Occlusion, Vascular | 5 | 2009 | 549 | 0.440 |
Why?
|
| Aorta, Thoracic | 4 | 2014 | 1082 | 0.430 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2015 | 1369 | 0.400 |
Why?
|
| Organometallic Compounds | 9 | 2000 | 665 | 0.400 |
Why?
|
| Wounds, Penetrating | 1 | 2014 | 307 | 0.400 |
Why?
|
| Thrombosis | 5 | 2011 | 2968 | 0.400 |
Why?
|
| Aneurysm | 3 | 2010 | 339 | 0.390 |
Why?
|
| Time Factors | 47 | 2021 | 40075 | 0.380 |
Why?
|
| Vascular Patency | 13 | 2012 | 886 | 0.380 |
Why?
|
| Urinary Retention | 2 | 2023 | 111 | 0.380 |
Why?
|
| Transplantation Tolerance | 4 | 2018 | 617 | 0.370 |
Why?
|
| Carotid Artery Diseases | 7 | 2020 | 882 | 0.360 |
Why?
|
| Treatment Outcome | 57 | 2023 | 63114 | 0.360 |
Why?
|
| Laser Therapy | 10 | 2002 | 1072 | 0.350 |
Why?
|
| Aortic Aneurysm, Thoracic | 8 | 2019 | 686 | 0.350 |
Why?
|
| Vena Cava Filters | 1 | 2012 | 252 | 0.350 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2010 | 153 | 0.350 |
Why?
|
| Risk Assessment | 23 | 2021 | 23338 | 0.350 |
Why?
|
| Thrombectomy | 2 | 2010 | 680 | 0.340 |
Why?
|
| Limb Salvage | 8 | 2013 | 433 | 0.340 |
Why?
|
| Patient Care Team | 1 | 2020 | 2531 | 0.340 |
Why?
|
| Saphenous Vein | 4 | 2009 | 532 | 0.340 |
Why?
|
| Blood Coagulation Disorders | 2 | 2010 | 337 | 0.330 |
Why?
|
| Graft Rejection | 8 | 2018 | 4397 | 0.330 |
Why?
|
| Aneurysm, Infected | 1 | 2009 | 85 | 0.330 |
Why?
|
| Angioplasty | 5 | 2016 | 364 | 0.330 |
Why?
|
| Crowns | 1 | 2009 | 152 | 0.330 |
Why?
|
| Major Histocompatibility Complex | 4 | 2015 | 936 | 0.330 |
Why?
|
| Kaplan-Meier Estimate | 19 | 2017 | 6538 | 0.320 |
Why?
|
| Heart Transplantation | 7 | 2018 | 3110 | 0.320 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2015 | 1821 | 0.320 |
Why?
|
| Renal Artery Obstruction | 7 | 2012 | 248 | 0.310 |
Why?
|
| Prosthesis Implantation | 1 | 2012 | 642 | 0.300 |
Why?
|
| Streptococcus agalactiae | 1 | 2009 | 375 | 0.300 |
Why?
|
| Anticoagulants | 3 | 2011 | 4599 | 0.300 |
Why?
|
| Aged | 94 | 2022 | 163280 | 0.290 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 1999 | 599 | 0.290 |
Why?
|
| Brachial Artery | 2 | 2002 | 369 | 0.290 |
Why?
|
| Indoles | 9 | 2000 | 1839 | 0.290 |
Why?
|
| Renal Artery | 9 | 2012 | 398 | 0.280 |
Why?
|
| Swine, Miniature | 7 | 2018 | 961 | 0.280 |
Why?
|
| Blood Vessels | 3 | 2002 | 1125 | 0.280 |
Why?
|
| Arteriosclerosis | 10 | 2004 | 1092 | 0.280 |
Why?
|
| Retrospective Studies | 54 | 2023 | 77449 | 0.270 |
Why?
|
| Histocompatibility | 3 | 2015 | 330 | 0.270 |
Why?
|
| Flow Cytometry | 2 | 2015 | 5974 | 0.260 |
Why?
|
| Endarterectomy | 8 | 2009 | 195 | 0.260 |
Why?
|
| Specialization | 2 | 2020 | 777 | 0.260 |
Why?
|
| Risk Factors | 41 | 2022 | 72290 | 0.260 |
Why?
|
| Jugular Veins | 2 | 2004 | 204 | 0.250 |
Why?
|
| Aortic Aneurysm | 7 | 2021 | 643 | 0.250 |
Why?
|
| Cattle | 9 | 2004 | 3922 | 0.250 |
Why?
|
| Hemoglobinometry | 1 | 2004 | 35 | 0.250 |
Why?
|
| Heparin | 1 | 2011 | 1637 | 0.240 |
Why?
|
| Endoleak | 2 | 2021 | 106 | 0.240 |
Why?
|
| Health Status Indicators | 1 | 2010 | 969 | 0.240 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 1179 | 0.230 |
Why?
|
| Deferoxamine | 1 | 2004 | 151 | 0.230 |
Why?
|
| Cells, Cultured | 14 | 2015 | 19229 | 0.230 |
Why?
|
| Swine | 9 | 2018 | 5917 | 0.230 |
Why?
|
| Lung Transplantation | 3 | 2018 | 1153 | 0.230 |
Why?
|
| Male | 107 | 2023 | 350118 | 0.230 |
Why?
|
| Thrombomodulin | 1 | 2003 | 102 | 0.220 |
Why?
|
| Free Radical Scavengers | 1 | 2004 | 216 | 0.220 |
Why?
|
| Oxyhemoglobins | 1 | 2004 | 216 | 0.220 |
Why?
|
| Lasers | 4 | 2001 | 952 | 0.220 |
Why?
|
| Gamma Rays | 2 | 2004 | 320 | 0.210 |
Why?
|
| Aged, 80 and over | 44 | 2021 | 57776 | 0.210 |
Why?
|
| Carotid Artery Injuries | 2 | 2000 | 96 | 0.210 |
Why?
|
| Stem Cells | 1 | 2015 | 3567 | 0.210 |
Why?
|
| Organ Preservation | 2 | 2015 | 331 | 0.210 |
Why?
|
| Humans | 137 | 2023 | 744343 | 0.210 |
Why?
|
| Female | 98 | 2022 | 380194 | 0.210 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2004 | 849 | 0.210 |
Why?
|
| Odds Ratio | 13 | 2017 | 9849 | 0.210 |
Why?
|
| Survival Rate | 18 | 2016 | 12788 | 0.210 |
Why?
|
| Aortic Diseases | 7 | 2014 | 742 | 0.200 |
Why?
|
| Spectrum Analysis | 1 | 2004 | 454 | 0.200 |
Why?
|
| Stroke | 12 | 2020 | 9981 | 0.200 |
Why?
|
| Radiation-Sensitizing Agents | 5 | 1997 | 358 | 0.200 |
Why?
|
| Thromboplastin | 1 | 2003 | 291 | 0.200 |
Why?
|
| Reoperation | 10 | 2013 | 4201 | 0.200 |
Why?
|
| Hypertension, Renovascular | 3 | 2012 | 123 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2004 | 8301 | 0.200 |
Why?
|
| Perfusion | 3 | 2015 | 1360 | 0.190 |
Why?
|
| Cell Adhesion | 3 | 2004 | 3144 | 0.190 |
Why?
|
| Middle Aged | 66 | 2021 | 213383 | 0.190 |
Why?
|
| Patient Selection | 11 | 2013 | 4215 | 0.190 |
Why?
|
| Carotid Artery, Common | 3 | 2016 | 183 | 0.190 |
Why?
|
| Proportional Hazards Models | 15 | 2021 | 12354 | 0.180 |
Why?
|
| Embolic Protection Devices | 1 | 2020 | 42 | 0.180 |
Why?
|
| Venous Thromboembolism | 1 | 2012 | 1671 | 0.180 |
Why?
|
| Sterilization | 1 | 2001 | 133 | 0.180 |
Why?
|
| Methylene Blue | 1 | 2000 | 155 | 0.180 |
Why?
|
| Rats | 20 | 2004 | 24260 | 0.180 |
Why?
|
| Blood Substitutes | 1 | 2000 | 58 | 0.180 |
Why?
|
| Graft Survival | 6 | 2018 | 3737 | 0.180 |
Why?
|
| Monitoring, Intraoperative | 5 | 2012 | 957 | 0.170 |
Why?
|
| Art | 1 | 2019 | 65 | 0.170 |
Why?
|
| Endothelium, Vascular | 3 | 2003 | 4456 | 0.170 |
Why?
|
| Porphyrins | 2 | 1999 | 348 | 0.170 |
Why?
|
| Indium Radioisotopes | 2 | 1989 | 118 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 2 | 1997 | 2007 | 0.170 |
Why?
|
| Arm | 1 | 2002 | 589 | 0.170 |
Why?
|
| Ultrasonography, Doppler, Duplex | 5 | 2016 | 205 | 0.170 |
Why?
|
| Animals | 46 | 2018 | 168757 | 0.160 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 390 | 0.160 |
Why?
|
| Angiography | 10 | 2017 | 1639 | 0.160 |
Why?
|
| Predictive Value of Tests | 8 | 2015 | 15076 | 0.160 |
Why?
|
| Carotenoids | 3 | 1991 | 624 | 0.160 |
Why?
|
| Hypotension | 2 | 2023 | 884 | 0.160 |
Why?
|
| Prosthesis Design | 6 | 2022 | 2110 | 0.160 |
Why?
|
| Brain Ischemia | 3 | 2018 | 3265 | 0.160 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2009 | 97 | 0.160 |
Why?
|
| Cerebral Revascularization | 1 | 2020 | 238 | 0.160 |
Why?
|
| Coronary Restenosis | 1 | 2001 | 424 | 0.160 |
Why?
|
| Hemoglobins | 2 | 2004 | 1534 | 0.150 |
Why?
|
| Kidney Transplantation | 4 | 2018 | 4251 | 0.150 |
Why?
|
| Vocal Cord Paralysis | 1 | 2020 | 267 | 0.150 |
Why?
|
| Staphylococcal Infections | 2 | 2001 | 1400 | 0.150 |
Why?
|
| Registries | 5 | 2020 | 8089 | 0.140 |
Why?
|
| Immune Tolerance | 2 | 2015 | 2258 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2016 | 2208 | 0.130 |
Why?
|
| Logistic Models | 12 | 2021 | 13408 | 0.130 |
Why?
|
| Radiography | 9 | 2014 | 7023 | 0.130 |
Why?
|
| Tunica Media | 2 | 2011 | 113 | 0.130 |
Why?
|
| Fascia | 1 | 1996 | 135 | 0.130 |
Why?
|
| Lipids | 2 | 2005 | 3305 | 0.130 |
Why?
|
| Aortic Rupture | 10 | 2021 | 310 | 0.130 |
Why?
|
| Aluminum | 5 | 1997 | 152 | 0.130 |
Why?
|
| Cell Division | 7 | 1999 | 4568 | 0.130 |
Why?
|
| Databases as Topic | 4 | 2011 | 475 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2018 | 413 | 0.130 |
Why?
|
| Hindlimb | 3 | 2013 | 504 | 0.130 |
Why?
|
| Arteries | 5 | 1994 | 1119 | 0.130 |
Why?
|
| Reperfusion Injury | 3 | 2008 | 1026 | 0.130 |
Why?
|
| Prosthesis-Related Infections | 1 | 2001 | 538 | 0.130 |
Why?
|
| Embolism | 2 | 2018 | 408 | 0.120 |
Why?
|
| Boston | 9 | 2016 | 9313 | 0.120 |
Why?
|
| Propensity Score | 3 | 2019 | 1781 | 0.120 |
Why?
|
| Severity of Illness Index | 12 | 2018 | 15540 | 0.120 |
Why?
|
| Brain Death | 1 | 2018 | 348 | 0.120 |
Why?
|
| Chi-Square Distribution | 7 | 2017 | 3508 | 0.120 |
Why?
|
| Muscle, Skeletal | 4 | 2018 | 4931 | 0.120 |
Why?
|
| Neurosurgery | 1 | 2020 | 643 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 18029 | 0.120 |
Why?
|
| Muscle Strength | 1 | 2018 | 592 | 0.120 |
Why?
|
| Histocompatibility Antigens | 1 | 2015 | 471 | 0.120 |
Why?
|
| Vasa Vasorum | 1 | 2013 | 26 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2019 | 4687 | 0.120 |
Why?
|
| Fibromuscular Dysplasia | 1 | 1994 | 58 | 0.120 |
Why?
|
| Pericardiocentesis | 1 | 2014 | 74 | 0.120 |
Why?
|
| Angioscopy | 1 | 1993 | 49 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 3255 | 0.110 |
Why?
|
| Diverticulum | 1 | 2014 | 136 | 0.110 |
Why?
|
| Blood Platelets | 2 | 2002 | 2508 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2000 | 1301 | 0.110 |
Why?
|
| Recurrence | 8 | 2014 | 8340 | 0.110 |
Why?
|
| Follow-Up Studies | 20 | 2017 | 39050 | 0.110 |
Why?
|
| Skin Transplantation | 2 | 2015 | 1074 | 0.110 |
Why?
|
| Diabetes Complications | 2 | 2010 | 1359 | 0.110 |
Why?
|
| Asymptomatic Diseases | 4 | 2018 | 551 | 0.110 |
Why?
|
| Intraoperative Complications | 4 | 2010 | 1198 | 0.110 |
Why?
|
| Inguinal Canal | 1 | 2012 | 69 | 0.110 |
Why?
|
| Free Radicals | 3 | 1997 | 237 | 0.110 |
Why?
|
| Veins | 3 | 1996 | 770 | 0.110 |
Why?
|
| Age Factors | 4 | 2020 | 18370 | 0.110 |
Why?
|
| Magnetic Resonance Angiography | 5 | 2018 | 1442 | 0.100 |
Why?
|
| Spinal Cord Ischemia | 2 | 2011 | 93 | 0.100 |
Why?
|
| Diabetic Foot | 1 | 2016 | 355 | 0.100 |
Why?
|
| Kidney | 4 | 2015 | 7186 | 0.100 |
Why?
|
| Reference Standards | 1 | 2015 | 1025 | 0.100 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 12245 | 0.100 |
Why?
|
| Platelet Factor 4 | 1 | 2011 | 129 | 0.100 |
Why?
|
| Heart | 2 | 2015 | 4467 | 0.100 |
Why?
|
| Cranial Nerve Injuries | 1 | 2010 | 25 | 0.100 |
Why?
|
| Aortography | 3 | 2010 | 437 | 0.100 |
Why?
|
| Neointima | 1 | 2011 | 135 | 0.100 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2011 | 285 | 0.100 |
Why?
|
| Fingers | 1 | 1994 | 513 | 0.090 |
Why?
|
| Tissue Donors | 3 | 2018 | 2240 | 0.090 |
Why?
|
| Gallium Radioisotopes | 1 | 1991 | 178 | 0.090 |
Why?
|
| Motor Cortex | 1 | 2018 | 986 | 0.090 |
Why?
|
| Ureteral Obstruction | 1 | 2012 | 296 | 0.090 |
Why?
|
| Cryopreservation | 1 | 2015 | 670 | 0.090 |
Why?
|
| Dissection | 1 | 1992 | 295 | 0.090 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 547 | 0.090 |
Why?
|
| Hypoglossal Nerve Diseases | 1 | 2010 | 8 | 0.090 |
Why?
|
| Skin | 1 | 2004 | 4364 | 0.090 |
Why?
|
| Iliac Aneurysm | 2 | 2000 | 38 | 0.090 |
Why?
|
| Leadership | 1 | 2019 | 1357 | 0.090 |
Why?
|
| Embolization, Therapeutic | 4 | 2008 | 1392 | 0.090 |
Why?
|
| Chronic Disease | 5 | 2012 | 9146 | 0.090 |
Why?
|
| Constriction, Pathologic | 3 | 2004 | 1107 | 0.090 |
Why?
|
| Phototherapy | 1 | 1993 | 377 | 0.090 |
Why?
|
| Focal Infection | 1 | 1989 | 9 | 0.090 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1991 | 219 | 0.090 |
Why?
|
| Apoptosis | 4 | 2015 | 9727 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 2 | 2011 | 1831 | 0.090 |
Why?
|
| Renal Insufficiency | 4 | 2012 | 804 | 0.090 |
Why?
|
| Polyamines | 3 | 1986 | 120 | 0.090 |
Why?
|
| Forecasting | 2 | 2017 | 2951 | 0.090 |
Why?
|
| Surgical Wound Infection | 3 | 2001 | 1540 | 0.090 |
Why?
|
| Anastomosis, Surgical | 5 | 1996 | 987 | 0.080 |
Why?
|
| Incidence | 7 | 2020 | 20947 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 2002 | 0.080 |
Why?
|
| Drug Substitution | 1 | 2011 | 281 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2012 | 20129 | 0.080 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2010 | 129 | 0.080 |
Why?
|
| Cell Movement | 4 | 2004 | 5217 | 0.080 |
Why?
|
| Back Pain | 1 | 2012 | 545 | 0.080 |
Why?
|
| Retreatment | 2 | 2021 | 610 | 0.080 |
Why?
|
| Paraganglioma | 1 | 2010 | 143 | 0.080 |
Why?
|
| Risk Adjustment | 1 | 2012 | 594 | 0.080 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 1989 | 138 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 3327 | 0.080 |
Why?
|
| Celiac Artery | 1 | 2008 | 69 | 0.080 |
Why?
|
| Analysis of Variance | 6 | 2005 | 6365 | 0.080 |
Why?
|
| Models, Animal | 3 | 2015 | 2171 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2014 | 850 | 0.080 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2018 | 1519 | 0.080 |
Why?
|
| Databases, Factual | 4 | 2020 | 7729 | 0.080 |
Why?
|
| Surgical Flaps | 1 | 1996 | 1640 | 0.080 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 687 | 0.070 |
Why?
|
| Device Removal | 1 | 2012 | 656 | 0.070 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1438 | 0.070 |
Why?
|
| Leukocytes | 1 | 2015 | 2043 | 0.070 |
Why?
|
| Splenic Artery | 1 | 2007 | 54 | 0.070 |
Why?
|
| Immunoglobulin G | 2 | 1989 | 4560 | 0.070 |
Why?
|
| Culture Media, Conditioned | 2 | 1999 | 537 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2016 | 8642 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2000 | 3870 | 0.070 |
Why?
|
| Decision Support Techniques | 2 | 2013 | 1956 | 0.070 |
Why?
|
| Ornithine Decarboxylase | 1 | 1986 | 63 | 0.070 |
Why?
|
| Mesentery | 1 | 2007 | 205 | 0.070 |
Why?
|
| Intestinal Polyps | 1 | 1986 | 100 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2012 | 1063 | 0.070 |
Why?
|
| Staphylococcus epidermidis | 2 | 2001 | 117 | 0.070 |
Why?
|
| Renal Dialysis | 3 | 2012 | 1786 | 0.070 |
Why?
|
| Shock, Cardiogenic | 1 | 1991 | 688 | 0.070 |
Why?
|
| Enoxaparin | 1 | 2008 | 377 | 0.070 |
Why?
|
| Electroencephalography | 4 | 2017 | 6150 | 0.070 |
Why?
|
| Groin | 1 | 2005 | 104 | 0.070 |
Why?
|
| Length of Stay | 5 | 2023 | 6309 | 0.060 |
Why?
|
| Phenanthrenes | 1 | 2005 | 63 | 0.060 |
Why?
|
| Lung | 2 | 2015 | 9856 | 0.060 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2005 | 49 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 1989 | 613 | 0.060 |
Why?
|
| Duodenum | 1 | 2008 | 483 | 0.060 |
Why?
|
| Random Allocation | 2 | 2000 | 2429 | 0.060 |
Why?
|
| Constriction | 3 | 2012 | 181 | 0.060 |
Why?
|
| Prognosis | 6 | 2021 | 29063 | 0.060 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3610 | 0.060 |
Why?
|
| Probability | 1 | 2009 | 2505 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2971 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2886 | 0.060 |
Why?
|
| Durable Medical Equipment | 1 | 2003 | 22 | 0.060 |
Why?
|
| Photochemistry | 1 | 2003 | 238 | 0.060 |
Why?
|
| Antibodies | 1 | 2011 | 2460 | 0.060 |
Why?
|
| Endothelin-1 | 2 | 2015 | 314 | 0.060 |
Why?
|
| Academic Medical Centers | 2 | 2012 | 2759 | 0.060 |
Why?
|
| Critical Illness | 3 | 2011 | 2670 | 0.060 |
Why?
|
| Hypertension | 1 | 2023 | 8480 | 0.060 |
Why?
|
| Aorta | 4 | 1997 | 2061 | 0.050 |
Why?
|
| Mastectomy, Radical | 1 | 2002 | 20 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 1991 | 1401 | 0.050 |
Why?
|
| Hyperemia | 1 | 2004 | 225 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 1992 | 2031 | 0.050 |
Why?
|
| Running | 1 | 2007 | 480 | 0.050 |
Why?
|
| Aneurysm, Ruptured | 1 | 2008 | 452 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 1987 | 518 | 0.050 |
Why?
|
| Photobiology | 1 | 2002 | 10 | 0.050 |
Why?
|
| United States | 8 | 2016 | 69872 | 0.050 |
Why?
|
| Kidney Function Tests | 3 | 2012 | 684 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9239 | 0.050 |
Why?
|
| Cytokines | 2 | 2018 | 7322 | 0.050 |
Why?
|
| Endoscopy | 2 | 2000 | 1785 | 0.050 |
Why?
|
| Disease-Free Survival | 4 | 2016 | 6895 | 0.050 |
Why?
|
| Adult | 28 | 2021 | 214055 | 0.050 |
Why?
|
| Aneurysm, Dissecting | 1 | 2001 | 11 | 0.050 |
Why?
|
| Calcinosis | 2 | 2003 | 1499 | 0.050 |
Why?
|
| Coronary Disease | 4 | 1996 | 6077 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2003 | 689 | 0.050 |
Why?
|
| Pancreas | 1 | 2008 | 1686 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2001 | 6487 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2000 | 69 | 0.050 |
Why?
|
| Versicans | 1 | 2000 | 33 | 0.050 |
Why?
|
| Disability Evaluation | 2 | 2018 | 1827 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2000 | 212 | 0.050 |
Why?
|
| Neoplasm Transplantation | 1 | 1984 | 2085 | 0.050 |
Why?
|
| Elastic Tissue | 1 | 2000 | 65 | 0.050 |
Why?
|
| Ankle Brachial Index | 2 | 2011 | 154 | 0.050 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2000 | 136 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2020 | 3068 | 0.040 |
Why?
|
| beta Carotene | 3 | 1991 | 527 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2000 | 279 | 0.040 |
Why?
|
| Colonic Neoplasms | 3 | 1986 | 2541 | 0.040 |
Why?
|
| Procollagen | 1 | 2000 | 185 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2004 | 1842 | 0.040 |
Why?
|
| Extremities | 2 | 2004 | 865 | 0.040 |
Why?
|
| Fibrosis | 3 | 2007 | 2029 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 5391 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 19905 | 0.040 |
Why?
|
| Transplantation, Homologous | 2 | 2000 | 4776 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 643 | 0.040 |
Why?
|
| Microcirculation | 1 | 2004 | 1286 | 0.040 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2020 | 139 | 0.040 |
Why?
|
| Pulsatile Flow | 2 | 2014 | 332 | 0.040 |
Why?
|
| Massachusetts | 2 | 2017 | 8663 | 0.040 |
Why?
|
| Atherosclerosis | 2 | 2013 | 3445 | 0.040 |
Why?
|
| Medicare | 2 | 2016 | 6566 | 0.040 |
Why?
|
| Urinary Catheterization | 1 | 2020 | 202 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2004 | 996 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2012 | 3209 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2149 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2002 | 894 | 0.040 |
Why?
|
| Blood Flow Velocity | 3 | 2014 | 1423 | 0.040 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 2025 | 0.040 |
Why?
|
| Actuarial Analysis | 3 | 2006 | 378 | 0.040 |
Why?
|
| Urodynamics | 1 | 2020 | 347 | 0.040 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 2046 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2002 | 669 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1970 | 0.040 |
Why?
|
| Premedication | 2 | 1989 | 258 | 0.040 |
Why?
|
| Intraoperative Care | 3 | 2005 | 767 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2006 | 2016 | 0.040 |
Why?
|
| Acute Disease | 3 | 2021 | 7149 | 0.040 |
Why?
|
| Lectins | 1 | 2000 | 513 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2018 | 354 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 1986 | 6364 | 0.040 |
Why?
|
| Intestines | 2 | 2021 | 1924 | 0.040 |
Why?
|
| Immunosuppressive Agents | 3 | 2015 | 4149 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2009 | 7181 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2005 | 1171 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2020 | 601 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 3 | 2014 | 935 | 0.040 |
Why?
|
| Hospitals, Private | 2 | 2009 | 63 | 0.040 |
Why?
|
| Inflammation | 4 | 2013 | 10638 | 0.040 |
Why?
|
| Growth Substances | 1 | 1999 | 784 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1999 | 625 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 1998 | 276 | 0.040 |
Why?
|
| Rectal Neoplasms | 1 | 1986 | 1206 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2000 | 835 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2000 | 588 | 0.040 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1996 | 53 | 0.040 |
Why?
|
| Nucleosomes | 1 | 2000 | 494 | 0.040 |
Why?
|
| Mesenteric Arteries | 2 | 2001 | 183 | 0.040 |
Why?
|
| Myocardial Revascularization | 1 | 2001 | 841 | 0.040 |
Why?
|
| Fibrinolytic Agents | 2 | 2018 | 2158 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2012 | 9959 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1403 | 0.030 |
Why?
|
| Podiatry | 1 | 2016 | 22 | 0.030 |
Why?
|
| Rats, Inbred ACI | 1 | 1995 | 44 | 0.030 |
Why?
|
| Rats, Inbred Strains | 4 | 1992 | 2186 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2000 | 1950 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 2289 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2000 | 1590 | 0.030 |
Why?
|
| Hemostasis, Surgical | 2 | 1996 | 128 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2011 | 1525 | 0.030 |
Why?
|
| Vocal Cords | 1 | 2020 | 528 | 0.030 |
Why?
|
| Duodenal Diseases | 1 | 1996 | 102 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10481 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2002 | 20822 | 0.030 |
Why?
|
| Omentum | 1 | 1996 | 170 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2004 | 1177 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2015 | 517 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 3047 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 1986 | 3036 | 0.030 |
Why?
|
| Cerebral Angiography | 2 | 2018 | 1285 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 1996 | 235 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 1988 | 2376 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 1995 | 322 | 0.030 |
Why?
|
| Paraplegia | 2 | 2011 | 168 | 0.030 |
Why?
|
| DNA | 4 | 2000 | 7301 | 0.030 |
Why?
|
| Diagnosis, Differential | 4 | 2010 | 12959 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 1996 | 355 | 0.030 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 6234 | 0.030 |
Why?
|
| New England | 1 | 2017 | 1022 | 0.030 |
Why?
|
| Endothelium | 1 | 1997 | 778 | 0.030 |
Why?
|
| Organ Preservation Solutions | 1 | 2014 | 98 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
| Subclavian Artery | 1 | 2014 | 130 | 0.030 |
Why?
|
| Disaccharides | 1 | 2014 | 171 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2004 | 9274 | 0.030 |
Why?
|
| Sensitivity and Specificity | 4 | 2004 | 14722 | 0.030 |
Why?
|
| Intraoperative Period | 2 | 1995 | 520 | 0.030 |
Why?
|
| Mannitol | 1 | 2014 | 181 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 1995 | 1162 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 2 | 1994 | 1504 | 0.030 |
Why?
|
| Cohort Studies | 6 | 2009 | 40561 | 0.030 |
Why?
|
| Electrolytes | 1 | 2014 | 282 | 0.030 |
Why?
|
| Histidine | 1 | 2014 | 313 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 1996 | 326 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1995 | 964 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 2015 | 741 | 0.030 |
Why?
|
| Hemodynamics | 3 | 2016 | 4199 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2018 | 648 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2013 | 111 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1994 | 2645 | 0.030 |
Why?
|
| Glutamates | 1 | 2014 | 398 | 0.030 |
Why?
|
| Plethysmography | 1 | 1993 | 180 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2018 | 2008 | 0.030 |
Why?
|
| Life Tables | 3 | 2000 | 370 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2014 | 437 | 0.030 |
Why?
|
| Neodymium | 1 | 1992 | 21 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 1999 | 1530 | 0.030 |
Why?
|
| Actins | 1 | 2000 | 2121 | 0.030 |
Why?
|
| Yttrium | 1 | 1992 | 35 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 612 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2001 | 1451 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 712 | 0.030 |
Why?
|
| Prospective Studies | 10 | 2020 | 53288 | 0.030 |
Why?
|
| Hospital Mortality | 2 | 2019 | 5317 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1998 | 1375 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 1998 | 11366 | 0.030 |
Why?
|
| Half-Life | 1 | 1993 | 661 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 5179 | 0.030 |
Why?
|
| Thallium Radioisotopes | 1 | 1992 | 139 | 0.030 |
Why?
|
| Glutathione | 1 | 2014 | 589 | 0.030 |
Why?
|
| Dipyridamole | 1 | 1992 | 145 | 0.030 |
Why?
|
| Hypothermia, Induced | 1 | 1997 | 752 | 0.030 |
Why?
|
| Risk | 1 | 2004 | 9687 | 0.020 |
Why?
|
| Paraparesis | 1 | 2011 | 14 | 0.020 |
Why?
|
| Neutrophils | 1 | 2004 | 3719 | 0.020 |
Why?
|
| Venae Cavae | 1 | 1991 | 41 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2015 | 679 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2015 | 743 | 0.020 |
Why?
|
| Citrates | 1 | 1991 | 131 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 1 | 1991 | 116 | 0.020 |
Why?
|
| Citric Acid | 1 | 1991 | 126 | 0.020 |
Why?
|
| Collagen | 1 | 1999 | 2689 | 0.020 |
Why?
|
| Spectrophotometry | 2 | 1988 | 313 | 0.020 |
Why?
|
| Bioprosthesis | 1 | 1995 | 596 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2014 | 772 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 4042 | 0.020 |
Why?
|
| Wound Healing | 2 | 2000 | 2785 | 0.020 |
Why?
|
| Medical Records | 1 | 2016 | 1413 | 0.020 |
Why?
|
| DNA Damage | 1 | 2000 | 2432 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4371 | 0.020 |
Why?
|
| Ligation | 2 | 2007 | 453 | 0.020 |
Why?
|
| Heart Diseases | 2 | 2018 | 2788 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 2 | 1985 | 5256 | 0.020 |
Why?
|
| Rabbits | 3 | 1993 | 4894 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 2011 | 287 | 0.020 |
Why?
|
| Endoscopes | 1 | 1990 | 175 | 0.020 |
Why?
|
| Splanchnic Circulation | 1 | 2009 | 110 | 0.020 |
Why?
|
| Ornithine | 2 | 1986 | 78 | 0.020 |
Why?
|
| Comorbidity | 2 | 2014 | 10388 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2014 | 604 | 0.020 |
Why?
|
| Young Adult | 2 | 2012 | 56430 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10252 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1997 | 1809 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2002 | 7913 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2013 | 3508 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 1989 | 588 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2013 | 1179 | 0.020 |
Why?
|
| Motor Activity | 1 | 2018 | 2714 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1992 | 662 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2023 | 3749 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2018 | 2925 | 0.020 |
Why?
|
| Hemoglobin A | 1 | 1988 | 87 | 0.020 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2008 | 40 | 0.020 |
Why?
|
| Equipment Design | 2 | 1996 | 3582 | 0.020 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 454 | 0.020 |
Why?
|
| Atherectomy | 1 | 2007 | 47 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1991 | 315 | 0.020 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1990 | 277 | 0.020 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 1988 | 83 | 0.020 |
Why?
|
| Abdomen, Acute | 1 | 2008 | 123 | 0.020 |
Why?
|
| Dogs | 1 | 1992 | 3912 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2017 | 5985 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2002 | 3537 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2015 | 896 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1989 | 981 | 0.020 |
Why?
|
| Spermidine | 1 | 1986 | 56 | 0.020 |
Why?
|
| Spermine | 1 | 1986 | 70 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2737 | 0.020 |
Why?
|
| Disease Progression | 2 | 2014 | 13284 | 0.020 |
Why?
|
| Vanadium | 1 | 1986 | 53 | 0.020 |
Why?
|
| Mitochondria | 1 | 1999 | 3520 | 0.020 |
Why?
|
| Safety | 1 | 1991 | 1186 | 0.020 |
Why?
|
| Thymidine | 1 | 1986 | 310 | 0.020 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 1985 | 41 | 0.020 |
Why?
|
| Shock, Hemorrhagic | 1 | 2008 | 220 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10397 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2011 | 798 | 0.020 |
Why?
|
| Administration, Oral | 2 | 1991 | 3913 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 1993 | 2699 | 0.020 |
Why?
|
| Tibial Arteries | 1 | 2005 | 57 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 2005 | 1827 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3527 | 0.020 |
Why?
|
| Aphasia | 1 | 1987 | 179 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1998 | 2400 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 1637 | 0.020 |
Why?
|
| Warfarin | 1 | 1994 | 1496 | 0.020 |
Why?
|
| Ulcer | 1 | 2006 | 209 | 0.020 |
Why?
|
| Shock | 1 | 2008 | 318 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2007 | 280 | 0.020 |
Why?
|
| Ticlopidine | 1 | 2011 | 899 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2004 | 35421 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2000 | 13033 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 1984 | 5686 | 0.020 |
Why?
|
| Cheek | 1 | 1984 | 63 | 0.020 |
Why?
|
| Mesocricetus | 1 | 1984 | 252 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1996 | 3461 | 0.020 |
Why?
|
| Regeneration | 1 | 2013 | 1485 | 0.010 |
Why?
|
| Aneurysm, False | 1 | 2006 | 276 | 0.010 |
Why?
|
| Shear Strength | 1 | 2004 | 165 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2016 | 3743 | 0.010 |
Why?
|
| Ileum | 1 | 1986 | 565 | 0.010 |
Why?
|
| Esophageal and Gastric Varices | 1 | 1985 | 207 | 0.010 |
Why?
|
| Postoperative Care | 2 | 2005 | 1486 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 2006 | 404 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2005 | 422 | 0.010 |
Why?
|
| Body Temperature | 2 | 1997 | 777 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3200 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 8949 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1996 | 2538 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1850 | 0.010 |
Why?
|
| Anesthesia, Conduction | 1 | 2006 | 238 | 0.010 |
Why?
|
| Oxygen | 1 | 2014 | 4189 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 21827 | 0.010 |
Why?
|
| Bile Duct Neoplasms | 1 | 1988 | 567 | 0.010 |
Why?
|
| Methods | 2 | 1995 | 1129 | 0.010 |
Why?
|
| Colon | 2 | 1991 | 1772 | 0.010 |
Why?
|
| Creatinine | 2 | 1999 | 1919 | 0.010 |
Why?
|
| Aspirin | 1 | 2014 | 3282 | 0.010 |
Why?
|
| Myocardium | 1 | 2015 | 4776 | 0.010 |
Why?
|
| Regression Analysis | 4 | 1995 | 6459 | 0.010 |
Why?
|
| Finite Element Analysis | 1 | 2004 | 431 | 0.010 |
Why?
|
| Linear Models | 1 | 1992 | 5952 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 12072 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 3670 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 1799 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2009 | 2453 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5751 | 0.010 |
Why?
|
| Telemedicine | 1 | 1998 | 2872 | 0.010 |
Why?
|
| Cricetinae | 1 | 1984 | 2472 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 2569 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15165 | 0.010 |
Why?
|
| Buttocks | 1 | 2000 | 110 | 0.010 |
Why?
|
| Mice | 5 | 2013 | 81183 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 11727 | 0.010 |
Why?
|
| Pressure Ulcer | 1 | 2000 | 155 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1991 | 10943 | 0.010 |
Why?
|
| Morbidity | 1 | 2004 | 1769 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14557 | 0.010 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1997 | 35 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5442 | 0.010 |
Why?
|
| Alcoholism | 1 | 2008 | 1906 | 0.010 |
Why?
|
| Sepsis | 1 | 2011 | 2593 | 0.010 |
Why?
|
| Carbohydrate Epimerases | 1 | 1975 | 43 | 0.010 |
Why?
|
| Erectile Dysfunction | 1 | 2000 | 461 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2002 | 2618 | 0.010 |
Why?
|
| Triose-Phosphate Isomerase | 1 | 1975 | 44 | 0.010 |
Why?
|
| Eflornithine | 2 | 1986 | 31 | 0.010 |
Why?
|
| Thermometers | 1 | 1996 | 46 | 0.010 |
Why?
|
| Epidural Space | 1 | 1997 | 124 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1996 | 71 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1681 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 1996 | 322 | 0.010 |
Why?
|
| Microcomputers | 1 | 1996 | 147 | 0.010 |
Why?
|
| Pulse | 1 | 1995 | 229 | 0.010 |
Why?
|
| Photography | 1 | 1998 | 520 | 0.010 |
Why?
|
| Compliance | 1 | 1994 | 104 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 862 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 2077 | 0.010 |
Why?
|
| Infrared Rays | 1 | 1996 | 249 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1995 | 341 | 0.010 |
Why?
|
| Cerebrospinal Fluid | 1 | 1997 | 534 | 0.010 |
Why?
|
| Pedigree | 2 | 1993 | 4644 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 1995 | 458 | 0.010 |
Why?
|
| Elasticity | 1 | 1994 | 657 | 0.010 |
Why?
|
| Pressure | 1 | 1996 | 1203 | 0.010 |
Why?
|
| Feedback | 1 | 1996 | 795 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 5655 | 0.010 |
Why?
|
| Reference Values | 2 | 1990 | 4982 | 0.010 |
Why?
|
| Tensile Strength | 1 | 1992 | 335 | 0.010 |
Why?
|
| Contrast Media | 2 | 1995 | 5300 | 0.010 |
Why?
|
| Anisotropy | 1 | 1994 | 1265 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 1998 | 1095 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2004 | 6196 | 0.010 |
Why?
|
| Gadolinium | 1 | 1995 | 952 | 0.010 |
Why?
|
| Sutures | 1 | 1992 | 299 | 0.010 |
Why?
|
| Retroperitoneal Space | 1 | 1990 | 176 | 0.010 |
Why?
|
| Temperature | 1 | 1996 | 2206 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1986 | 11483 | 0.010 |
Why?
|
| Peritoneum | 1 | 1990 | 228 | 0.010 |
Why?
|
| Absorption | 1 | 1988 | 248 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2004 | 8554 | 0.010 |
Why?
|
| Cystic Duct | 1 | 1988 | 19 | 0.010 |
Why?
|
| Hepatic Duct, Common | 1 | 1988 | 50 | 0.000 |
Why?
|
| Feasibility Studies | 1 | 1998 | 5078 | 0.000 |
Why?
|
| Rest | 1 | 1993 | 901 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1985 | 4262 | 0.000 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1988 | 111 | 0.000 |
Why?
|
| Critical Care | 1 | 2000 | 2647 | 0.000 |
Why?
|
| Sheep | 1 | 1990 | 1437 | 0.000 |
Why?
|
| 1,2-Dimethylhydrazine | 1 | 1986 | 8 | 0.000 |
Why?
|
| Dimethylhydrazines | 1 | 1986 | 12 | 0.000 |
Why?
|
| Cocarcinogenesis | 1 | 1986 | 54 | 0.000 |
Why?
|
| Respiration Disorders | 1 | 1990 | 371 | 0.000 |
Why?
|
| RNA | 2 | 1986 | 2749 | 0.000 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1988 | 504 | 0.000 |
Why?
|
| Pain | 1 | 2000 | 4986 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1994 | 2250 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1988 | 1572 | 0.000 |
Why?
|
| Exercise Test | 1 | 1992 | 2074 | 0.000 |
Why?
|
| Colonoscopy | 1 | 1991 | 1367 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1994 | 1876 | 0.000 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1985 | 520 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1985 | 13695 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1986 | 1460 | 0.000 |
Why?
|
| Adaptation, Physiological | 1 | 1986 | 1312 | 0.000 |
Why?
|
| Emergencies | 1 | 1985 | 1170 | 0.000 |
Why?
|
| Smoking | 1 | 1994 | 8987 | 0.000 |
Why?
|
| Hydroxymercuribenzoates | 1 | 1975 | 5 | 0.000 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 1975 | 21 | 0.000 |
Why?
|
| Aging | 1 | 1994 | 8664 | 0.000 |
Why?
|
| Body Weight | 1 | 1986 | 4669 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1975 | 2557 | 0.000 |
Why?
|
| Muscles | 1 | 1975 | 1614 | 0.000 |
Why?
|
| Kinetics | 1 | 1975 | 6473 | 0.000 |
Why?
|
| Binding Sites | 1 | 1975 | 6114 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1975 | 2752 | 0.000 |
Why?
|
| Protein Binding | 1 | 1975 | 9386 | 0.000 |
Why?
|
| Adolescent | 1 | 1988 | 85781 | 0.000 |
Why?
|